-
Hepatitis C virus (HCV) infection results in both acute and chronic hepatitis.
-
Torcetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, has been in development by Pfizer for nearly 15 years.
-
Greenfield RH. Red and potentially red/purple? Cranberry juice and warfarin. 2007;9(5):36-37.
-
O'Mathuna DP. Garlic and cardiovascular disease. Altern Ther Women's Health 2007;9(5):33-36.
-
Greenfield RH. Smarting from fish? Seafood consumption and pregnancy. 2007;9(5):37-39.
-
-
A survey of patients who attended an infertility clinic in South Australia found that 66% had used complementary medicine.
-
A Connecticut research group wanted to see if they could develop a way to measure HIV medication adherence both cost-effectively and accurately.
-
On March 26, 2007, FDA granted tentative approval for a generic drug formulation of efavirenz tablets (600 mg), manufactured by Strides Acrolab Ltd., Bangalore, India, under the expedited review provisions created by FDA for the President's Emergency Plan for AIDS Relief (PEPFAR).
-
This paper reports the results of an important multinational trial which evaluated the use of 2 different regimens of posaconazole in the treatment of OPC or EC, which had been refractory to either fluconazole or itraconazole.
